论文部分内容阅读
目的:探讨孕康糖浆结合西药治疗先兆流产(孕12-20周)的临床疗效。方法:选择2009年9月～2011年9月在医院治疗先兆流产(孕12～20周)的160例患者,随机分为对照组和治疗组各80例,对照组予常规西药治疗,治疗组加服孕康糖浆,观察临床疗效并记录治疗中的不良反应。结果:与对照组比较,治疗组治愈率、有效率均明显较高(P<0.05);两组治疗过程中均无不良反应发生。结论:孕康糖浆结合西药治疗孕12～20周出现的先兆流产安全有效,值得临床推广。
Objective: To investigate the clinical efficacy of pregnant Kang syrup combined with western medicine in the treatment of threatened abortion (pregnant 12-20 weeks). Methods: A total of 160 patients with threatened abortion (from 12 to 20 weeks pregnant) in the hospital from September 2009 to September 2011 were randomly divided into control group and treatment group (n = 80). The control group was treated with conventional western medicine. The treatment group Plus take pregnant syrup, observe the clinical efficacy and record the adverse reactions in the treatment. Results: Compared with the control group, the cure rate and effective rate were significantly higher in the treatment group (P <0.05). No adverse reactions occurred in the two groups during the treatment. Conclusion: Pregnancy syrup combined with western medicine is safe and effective in the treatment of threatened abortion in 12 to 20 weeks of pregnancy, which is worthy of clinical promotion.